Institutional report - Assisted circulation sensitisation and post-transplant course after the implantation of ventricular assist device

Interactive Cardiovascular and Thoracic Surgery

Volumn 8, Issue 3, 2009, Pages 339-342

  Malickaite, Radvile ^a   Rucinskas, Kestutis ^a   Staneviciene, Aldona ^a   Miniauskas, Saulius ^a   Maneikiene, Vyte ^a   Zuoziene, Gitana ^a   Sirvydis, Vytautas ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Sensitisation; Transplantation; Ventricular assist devices

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HLA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; ALLOANTIBODY; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; CLINICAL ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HUMAN; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIZATION; AGED; ANTIBODY PRODUCTION; ARTICLE; BLOOD; CHILD; COMPARATIVE STUDY; DESENSITIZATION; DRUG COMBINATION; DRUG EFFECT; GRAFT SURVIVAL; HEART FAILURE; IMMUNOLOGY; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; DESENSITIZATION, IMMUNOLOGIC; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 61849091965     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2008.192567     Document Type: Conference Paper

References (11)

1. Pollock-BarZiv SM, den Hollander N, Ngang B-Y, Kantor P, McMcrindle B, Dipchand AI. Pediatric heart transplantation in human leukocyte antigen-sensitized patients: evolving management and assessment of intermediate-term outcomes in high-risk population. Circulation 2007; 116(Suppl I):I-172-I-178.
2. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Koashigawa J, Abrams J, Anderson CB, Angelini A, Berry GJ, Burke MM, Demetris AJ, Hammond E, Itescu S, Marboe ChC, McManus B, Reed EF, Reinsmoen NL, Rodriguez ER, Rose AG, Rose M, Suciu-Focia N, Zeevi A, Billingham ME. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24:1700-1720.
3. Mahle WT, Naftel DC, Rusconi P, Edens RE, Shaddy RE, Group PHTS. Panel-reactive antibody cross-reactivity and outcomes in the Pediatric Heart Transplant Study Group. J Heart Lung Transplant 2004;23(Suppl 2):S167.
4. John R, Lietz K, Schuster M, Naka Y, Vivek R, Mancini DM, Rose EA, Smith CR, Oz MC, Edwards NM, Itescu S. Immunologic sensitisation in recipients of left ventricular assist devices. J Thorac Cardiovasc Surg 2003;125:578-591.
5. Joyce DL, Southard RE, Torre-Amione G, Noon GP, Land GA, Loebe M. Impact of left ventricular assist device (LVAD) -mediated humoral sensitisation on post-transplant outcomes. J Heart Lung Transplant 2005; 24:2054-2059.
6. Massad MG, Cook DJ, Stiven K, Schmitt SK, Smedira NG, McCarthy JF, Vargo RL, McCarthy PM. Factors influencing HLA sensitisation in implantable LVAD recipients. Ann Thorac Surg 1997;64:1120-1125.
7. Kirsch L, Timmermans T, Van Caenegem O, Gurne O, Noirhomme P, Jacquet L-M, Latinne D, Poncelet AJ. Allosensitization in bridge to trasplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy. Eur J Cardiothorac Surg 2008;34:26874.
8. Betkowski AS, Graff R, Chen JJ, Hauptman PJ. Panel-reactive antibody screening practises prior to heart transplantation. J Heart Lung Transplant 2002;21:644-650.
9. Nwakanma LU, Williams JA, Weis ES, Russell SD, Baumgartner WA, Conte JV. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg 2007;84:1556-1563.
10. Gonzalez-Strawinski GV, Cook DJ, Smedira NG, Navia JL, Taylor DO, Yamani MH, Hoercher K, Starling RC, Banbury MK. Attrition from heart transplantat waiting list for patients on ventricular assist devices is not affected by desensitisation strategies. Transplantation Proceedings 2007;39:1571-1572.
11. Gonzalez-Strawinski GV, Cook DJ, Chang ASY, Banbury MK, Navia JL, Hoercher K, Lober C, Atik FA, Taylor DO, Yamani MH, Young JB, Starling RC, Smedira NG. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival. J Heart Lung Transplant 2006;25:613-618.